Sentiment-Signal
3,8
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (20.03.2026)
HOCH Abgang Schlüsselpersonen (09.03.2026)
HOCH Abgang Schlüsselpersonen (20.03.2026)
HOCH Abgang Schlüsselpersonen (09.03.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 20.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 09.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 30.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 06.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 12.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 06.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 18.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 14.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | nce in such filing. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain |
| 01.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ired by law. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer |
| 27.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 30.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
Stammdaten
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Unternehmen & Branche
| Name | NU SKIN ENTERPRISES, INC. |
|---|---|
| Ticker | NUS |
| CIK | 0001021561 |
| Boerse | US |
| Sektor | Consumer Defensive |
| Industrie | Household & Personal Products |
| SIC | 5122 · Wholesale-Drugs, Proprietaries & Druggists' Sundries |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 350,6 Mio. USD |
| Beta | 1,07 |
| Dividendenrendite | 0,24 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,485,159,000 | 160,204,000 | 3.18 | 1,405,313,000 | 805,240,000 |
| 2025-09-30 | 10-Q | 364,211,000 | 17,079,000 | 0.34 | 1,424,406,000 | 799,795,000 |
| 2025-06-30 | 10-Q | 386,138,000 | 21,119,000 | 0.43 | 1,443,693,000 | 787,754,000 |
| 2025-03-31 | 10-Q | 364,490,000 | 107,515,000 | 2.14 | 1,391,411,000 | 753,969,000 |
| 2024-12-31 | 10-K | 1,732,084,000 | -146,594,000 | -2.95 | 1,468,914,000 | 651,455,000 |
| 2024-09-30 | 10-Q | 430,145,000 | 8,302,000 | 0.17 | 1,582,895,000 | 706,875,000 |
| 2024-06-30 | 10-Q | 439,081,000 | -118,258,000 | -2.38 | 1,585,972,000 | 686,164,000 |
| 2024-03-31 | 10-Q | 417,306,000 | -533,000 | -0.01 | 1,741,915,000 | 810,206,000 |
| 2023-12-31 | 10-K | 1,969,131,000 | 8,595,000 | 0.17 | 1,808,626,000 | 821,968,000 |
| 2023-09-30 | 10-Q | 498,772,000 | -36,955,000 | -0.74 | 1,793,091,000 | 822,187,000 |
| 2023-06-30 | 10-Q | 500,257,000 | 26,892,000 | 0.54 | 1,893,776,000 | 895,345,000 |
| 2023-03-31 | 10-Q | 481,462,000 | 11,376,000 | 0.23 | 1,824,645,000 | 892,970,000 |
| 2022-12-31 | 10-K | 2,225,659,000 | 104,778,000 | 2.07 | 1,820,970,000 | 897,296,000 |
| 2022-09-30 | 10-Q | 537,805,000 | -25,390,000 | -0.51 | 1,763,172,000 | 841,934,000 |
| 2022-06-30 | 10-Q | 560,615,000 | 34,237,000 | 0.67 | 1,900,901,000 | 941,035,000 |
| 2022-03-31 | 10-Q | 604,899,000 | 38,716,000 | 0.76 | 1,892,249,000 | 934,200,000 |
| 2021-12-31 | 10-K | 2,695,669,000 | 147,266,000 | 2.86 | 1,906,480,000 | 912,772,000 |
| 2021-09-30 | 10-Q | 641,152,000 | 49,729,000 | 0.97 | 1,974,409,000 | 936,477,000 |
| 2021-06-30 | 10-Q | 704,055,000 | 59,338,000 | 1.15 | 2,049,980,000 | 917,826,000 |
| 2021-03-31 | 10-Q | 677,026,000 | 47,430,000 | 0.91 | 1,950,099,000 | 871,474,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-11-11 | Hatchett Steven Keith | Officer, Chief Product Officer | Open Market Purchase | 5,500 | 9.61 | 52,855.00 | +44,0% | |
| 2025-09-04 | Nathanson Laura | Director | Open Market Sale | -6,489 | 12.22 | -79,295.58 | -66,0% | |
| 2025-09-03 | Clark Chayce David | Officer, EVP and General Counsel | Open Market Sale | -20,000 | 11.97 | -239,400.00 | -199,3% | |
| 2025-08-29 | CAMPBELL DANIEL W | Director | Open Market Sale | -23,391 | 12.10 | -283,031.10 | -235,7% | |
| 2025-08-29 | CAMPBELL DANIEL W | Director | Open Market Sale | -9,046 | 12.12 | -109,637.52 | -91,3% | |
| 2025-06-02 | WOODBURY EDWINA D | Director | Open Market Sale | -4,532 | 8.44 | -38,250.08 | -31,8% | |
| 2025-06-02 | Battle Emma S. | Director | Open Market Sale | -4,532 | 8.44 | -38,250.08 | -31,8% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.